November 22nd 2024
Iron deficiency represents more than a medical condition; it is a reflection of persistent health disparities, according to an editorial published in The Lancet Haematology.
Need for PrEP Support Services Persists Among Latino MSM
October 4th 2023Among Latino men who have sex with men (MSM), access to and use of pre-exposure prophylaxis (PrEP) remain at suboptimal levels, despite this population of individuals having disproportionately high rates of diagnosed HIV in the United States.
Read More
ACCC National Oncology Conference to Focus on Reimagining Innovation in Cancer Care
October 3rd 2023This year’s 40th National Oncology Conference from the Association of Community Cancer Centers (ACCC) will take place in Austin, Texas, from October 4-6, with content designed to reflect the theme of “Reimagining Innovation.”
Read More
In this interview from our recent Institute for Value-Based Medicine® event, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the positive impact that Choosing Wisely and enhanced recovery after surgery, or EROS, protocols have had on patients receiving treatment for breast cancer.
Watch
Health Affairs Challenges Systemic Racism in Health Care
October 2nd 2023The October issue of Health Affairs examines the multifaceted aspects of structural racism in health care, exploring historical roots, policy implications, public biases, innovative solutions, and institutional challenges, urging action to confront and dismantle disparities.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
The Framework for Embracing Gene Therapy in Hemophilia Treatment
September 30th 2023Although gene therapy is anticipated to bring positive changes for people with hemophilia, choosing to receive gene therapy will require empowerment, participation, and shared decision-making, investigators write.
Read More
Altuviiio sBLA for Severe Hemophilia A in Children Accepted by FDA
September 29th 2023The supplemental biologics license application (sBLA) is supported by the results of the XTEND-Kids study, demonstrating a once-weekly 50 IU/kg dose of antihemophilic factor (recombinant) provides effective bleed protection in children with hemophilia A and can be used across clinical scenarios.
Read More
Dato-Dxd Shows Survival Improvements in HR+/HER2– Breast Cancer
September 29th 2023The dual primary end points of overall survival and progression-free survival were encouraging when patients with hormone receptor–positive (HR+), HER2-negative (HER2–) breast cancer were treated with datopotamab deruxtecan.
Read More
Subanalysis of ADAPT Reveals Consistent Efficacy With Efgartigimod Among All Genders
September 29th 2023Patients with generalized myasthenia gravis treated with efgartigimod consistently exceeded treatment compared with placebo regardless of gender in age, disease duration, body mass index, and thymectomy.
Read More
Surgery, Radiation for PCa Show Equal Efficacy in Candidates for Renal Transplantation
September 27th 2023A recent study suggests that patients with high-risk prostate cancer (PCa) in need of renal transplantation should receive cancer treatment before their transplants, as surgery and radiation treatment for localized PCa appear to be equally effective in this patient population.
Read More
Collaboration Is Key to Success in Alternative Payment Models, Says COA’s Nick Ferreyros
September 27th 2023The number one ingredient that an oncology-based alternative payment model needs to succeed is collaboration, explained Nicolas Ferreyros, managing director of policy, advocacy, and communications, Community Oncology Alliance (COA).
Watch
ICI Treatment Necessitates Close Monitoring of Potential Myasthenia Gravis
September 25th 2023Overactivation of the immune system is a potential serious adverse event (AE) following immune checkpoint inhibition (ICI) treatment for any of several cancers in the first and second line; among these AEs is myasthenia gravis.
Read More
Transforming Health Care: Insights From Industry Leaders on Health Equity and Policy
September 25th 2023At the National Comprehensive Cancer Network Oncology Policy Summit, prominent figures in the health care industry from diverse organizations emphasized a commitment to advancing health equity and addressing pressing social and health disparities.
Read More